KFG Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,054
Closed -$562K 227
2025
Q3
$562K Sell
2,054
-342
-14% -$93.4K 0.08% 114
2025
Q2
$618K Buy
2,396
+170
+8% +$40.6K 0.1% 112
2025
Q1
$498K Sell
2,226
-367
-14% -$85.7K 0.09% 116
2024
Q4
$593K Buy
2,593
+40
+2% +$9.63K 0.11% 94
2024
Q3
$623K Sell
2,553
-18
-0.7% -$4.02K 0.14% 94
2024
Q2
$492K Buy
2,571
+37
+1% +$7.51K 0.2% 92
2024
Q1
$502K Sell
2,534
-119
-4% -$21.8K 0.21% 87
2023
Q4
$456K Sell
2,653
-45
-2% -$6.91K 0.21% 82
2023
Q3
$399K Buy
+2,698
New +$488K 0.22% 84

Other funds holding RMD

KFG Wealth Management's RMD Position: Q4 2025 in Review

KFG Wealth Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 2,054 shares — an estimated $562K sold.

KFG Wealth Management first reported a position in RMD in Q3 2023 and held it in 9 quarters. The position peaked at $623K in Q3 2024. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • KFG Wealth Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • KFG Wealth Management sold 2,054 ResMed shares in Q4 2025, an estimated $562K.
  • KFG Wealth Management first reported a position in ResMed in Q3 2023 and held it in 9 quarters.
  • KFG Wealth Management's ResMed position peaked at $623K in Q3 2024.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on KFG Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.